The most common local adverse event in the short-term studies of ELIDEL Cream in pediatric patients ages 2-17 was application site burning (10% vs. 13% vehicle); the incidence in the long-term study was 9% ELIDEL vs. 7% vehicle (see ADVERSE REACTIONS).
The most common application site reaction was application site burning, which occurred in 8%-26% of patients treated with ELIDEL Cream.
Section
Not stated
Context
Most common local adverse event in pediatric patients ages 2–17; incidence reported in short-term and long-term studies.